Chordate Medical Holding AB Logo

Chordate Medical Holding AB

Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.

CMH | ST

Overview

Corporate Details

ISIN(s):
SE0021486131 (+1 more)
LEI:
549300R0GG2J3S0BFN79
Country:
Sweden
Address:
C/O Regus, 164 40 Kista
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Chordate Medical Holding AB is a medical technology company that has developed, patented, and CE-marked Ozilia®, a drug-free neuromodulation treatment technology. The product is designed for the treatment of chronic migraine and chronic rhinitis, offering a clinically proven alternative to conventional medication with minimal side effects. The company markets its treatment in selected markets within the EU and the Middle East. Its business strategy is focused on building value through clinical validation, an extensive patent portfolio, and commercial success stories to attract prospective buyers for a future exit.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Chordate Medical Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chordate Medical Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chordate Medical Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Tommy Hedberg Other Other 2,917 11,668.00 SEK
2024-03-26 Anders Weilandt Other Buy 800,000 41,440.00 SEK
2024-03-26 Anders Weilandt Other Buy 200,000 10,540.00 SEK
2023-05-26 Anders Weilandt Other Buy 2,000,000 84,000.00 SEK
2023-05-26 Jan Hermansson Other Buy 750,000 31,500.00 SEK
2023-05-26 Nils Henrik Milton Rammer Other Other 350,000 14,700.00 SEK
2023-05-26 Caroline Brandberg Other Other 225,000 9,450.00 SEK
2023-05-26 Tommy Hedberg Other Buy 225,000 9,450.00 SEK
2023-01-09 Anders Weilandt Other Buy 3 2.10 SEK
2022-02-25 Anders Weilandt Other Buy 51,292 3,949,484.00 SEK

Peer Companies

GENORAY Co., LTD. Logo
Global developer & manufacturer of medical and dental digital X-ray imaging equipment.
South Korea
122310
HeartBeam, Inc. Logo
Developing portable ECG solutions that synthesize a 12-lead ECG for remote cardiac monitoring.
United States of America
BEAT
HeartSciences Inc. Logo
AI-powered ECG technology for early detection of heart disease and advanced diagnostics.
United States of America
HSCS
Hironic Co.,Ltd Logo
Global manufacturer of HIFU, RF & Laser aesthetic devices for medical professionals worldwide.
South Korea
149980
Hyperfine, Inc. Logo
Develops the first FDA-cleared portable, point-of-care MRI for bedside brain imaging.
United States of America
HYPR
I.M.D. International Medical Devices Logo
Designs and manufactures X-ray diagnostic imaging systems and components for the medical sector.
Italy
IMD
InBody Co., Ltd. Logo
Develops professional BIA body composition analyzers for medical, fitness, and research.
South Korea
041830
InMode Ltd. Logo
Designs and manufactures energy-based aesthetic medical solutions for professionals.
United States of America
INMD
Inogen Inc Logo
Manufactures portable oxygen concentrators for homecare, enhancing patient mobility.
United States of America
INGN
Inspire Medical Systems, Inc. Logo
Provides an implantable neurostimulation therapy for obstructive sleep apnea as a CPAP alternative.
United States of America
INSP

Talk to a Data Expert

Have a question? We'll get back to you promptly.